Advisory Committee on Organ Transplantation, 1334-1335 [E7-212]
Download as PDF
<![CDATA[
1334
Federal Register / Vol. 72, No. 7 / Thursday, January 11, 2007 / Notices
cprice-sewell on PROD1PC66 with NOTICES
Public comments are invited, and may
be filed with the Commission in either
paper or electronic form. All comments
should be filed as prescribed in the
ADDRESSES section above, and must be
received on or before the date specified
in the DATES section.
Analysis of Agreement Containing
Consent Order To Aid Public Comment
The Federal Trade Commission has
accepted, subject to final approval, an
agreement containing a consent order
from Goen Technologies Corp.,
Nutramerica Corp., TrimSpa, Inc., and
Alexander Szynalski a/k/a Alexander
Goen (together, ‘‘respondents’’).
The proposed consent order has been
placed on the public record for thirty
(30) days for receipt of comments by
interested persons. Comments received
during this period will become part of
the public record. After thirty (30) days,
the Commission will again review the
agreement and the comments received,
and will decide whether it should
withdraw from the agreement or make
final the agreement’s proposed order.
This matter involves the advertising
and promotion of TrimSpa Completely
Ephedra Free Formula X32 (‘‘TrimSpa
X32’’), a dietary supplement that,
according to its label, contains, among
other ingredients, Hoodia gordonii,
chromium, vanadium, glucomannan,
citrus naringine, glucosamine HCI,
cocoa extract, and green tea extract.
According to the FTC complaint,
respondents represented that TrimSpa
X32 causes rapid and substantial weight
loss; and that Hoodia gordonii—an
African appetite suppressant—in
TrimSpa X32 enables users to lose
substantial amounts of weight by
suppressing their appetite. The
complaint alleges that respondents
failed to have substantiation for these
claims. The proposed consent order
contains provisions designed to prevent
respondents from engaging in similar
acts and practices in the future.
Part I of the proposed order requires
respondents to have competent and
reliable scientific evidence
substantiating any claims that a covered
product or service causes rapid and
substantial weight loss or that the
Hoodia gordonii, or any other appetite
suppressant, in a covered product
enables users to lose substantial
amounts of weight by suppressing their
appetite. The provision further requires
that any such claim be true. A ‘‘covered
product or service’’ is defined as ‘‘any
dietary supplement, food, drug, or
device, or any health-related service or
program.’’ Part I.C. further requires that
future claims about the health benefits,
performance, efficacy, safety, or side
VerDate Aug<31>2005
15:52 Jan 10, 2007
Jkt 211001
effects of any covered product or service
be truthful and supported by competent
and reliable scientific evidence.
Part II of the proposed order provides
that the order does not prohibit
respondents from making
representations for any drug that are
permitted in labeling for the drug under
any tentative final or final Food and
Drug Administration (‘‘FDA’’) standard
or under any new drug application
approved by the FDA; representations
for any medical device that are
permitted in labeling under any new
medical device application approved by
the FDA; and representations for any
product that are specifically permitted
in labeling for that product by
regulations issued by the FDA under the
Nutrition Labeling and Education Act of
1990.
Part III provides for the payment of
$1,500,000 to the Commission.
Part IV of the proposed order requires
respondents to provide the Commission
with a list of all consumers who
respondents know purchased TrimSpa
X32 from March 1, 2003 through the
date of entry of this Order.
Parts V through IX require
respondents to keep copies of relevant
advertisements and materials
substantiating claims made in the
advertisements; to provide copies of the
order to certain of their personnel; to
notify the Commission of changes in
corporate structure (for the corporate
respondents) and changes in
employment (for the individual
respondent) that might affect
compliance obligations under the order;
and to file compliance reports with the
Commission. Part X provides that the
order will terminate after twenty (20)
years under certain circumstances.
The purpose of this analysis is to
facilitate public comment on the
proposed order, and it is not intended
to constitute an official interpretation of
the agreement and proposed order or to
modify in any way their terms.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
By direction of the Commission, with
Commissioner Rosch recused.
Donald S. Clark,
Secretary.
[FR Doc. E7–206 Filed 1–10–07; 8:45 am]
Health Resources and Services
Administration
BILLING CODE 6750–01–P
AGENCY:
PO 00000
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control; Special
Emphasis Panel: Musculoskeletal
Research on Occupational Safety,
Program Announcement (PA) 04–038
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting of the
aforementioned Special Emphasis
Panel.
Time and Date: 1 p.m.–2 p.m., January 29,
2007 (Closed).
Place: National Institute for Occupational
Safety and Health (NIOSH), CDC, 626
Cochrans Mill Road, Pittsburgh, PA 15236.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the review, discussion, and
evaluation of a research grant application in
response to ‘‘Musculoskeletal Research on
Occupational Safety,’’ PA 04–038.
For Further Information Contact: George
Bokosh, Scientific Review Administrator,
NIOSH, 626 Cochrans Mill Road, Pittsburgh,
PA 15236, telephone (412) 386–6465.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: January 4, 2007.
Elaine Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–215 Filed 1–10–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Advisory Committee on Organ
Transplantation
Health Resources and Services
Administration (HRSA), HHS.
ACTION: Notice of ACOT Meeting to be
held by Conference Call.
SUMMARY: The Advisory Committee on
Organ Transplantation (ACOT) will be
conducting a conference call to discuss
Frm 00026
Fmt 4703
Sfmt 4703
E:\FR\FM\11JAN1.SGM
11JAN1
cprice-sewell on PROD1PC66 with NOTICES
Federal Register / Vol. 72, No. 7 / Thursday, January 11, 2007 / Notices
the revision of the Uniform Anatomical
Gift Act (UAGA).
DATES: The conference call will be held
on January 26, 2007, at 12 noon to 1
p.m. EST. Participants must dial: (888)
946–7610 and enter the corresponding
pass code 30431. For security reasons,
the pass code 30431 and Remy Aronoff’s
name, as call leader, are required to join
the call. Participants should call no later
than 11:50 a.m. EST in order for the
logistics to be set up. Participants are
asked to register for the conference by
contacting Diane Cheslosky at (301)
443–6839 or e-mail
diane.cheslosky@hrsa.hhs.gov. The
registration deadline is January 24,
2007. The Department will try to
accommodate those wishing to
participate in the call.
Any member of the public can submit
written materials that will be distributed
to Committee members prior to the
conference call. Parties wishing to
submit written comments should ensure
that the comments are postmarked or emailed no later than January 24, 2007,
for consideration. Comments should be
submitted to Remy Aronoff, Executive
Secretary, ACOT, Healthcare Systems
Bureau, HRSA, Parklawn Building,
Room 12C–06, 5600 Fishers Lane,
Rockville, Maryland 20857; telephone
(301) 443–3264; fax (301) 594–6095; or
e-mail: remy.aronoff@hrsa.hhs.gov.
Members of the public can present
oral comments during the conference
call during the public comment period.
If a member of the public wishes to
speak, the Department should be
notified at the time the participant
registers. Other members of the public
will be allocated time if time permits.
FOR FURTHER INFORMATION CONTACT:
Remy Aronoff, Executive Secretary,
ACOT, Healthcare Systems Bureau,
HRSA, Parklawn Building, Room 12C–
06, 5600 Fishers Lane, Rockville,
Maryland 20857; telephone (301) 443–
3264; fax (301) 594–6095; or e-mail:
remy.aronoff@hrsa.hhs.gov.
SUPPLEMENTARY INFORMATION: The
UAGA is a model law drafted by the
National Conference of Commissioners
on Uniform State Laws in an effort to
achieve uniformity among the
anatomical gift laws of the States. Three
ACOT recommendations provided a
stimulus for revising the UAGA. In
particular, recommendation number 10
(recommendation to engage in
legislative strategies to encourage
medical examiners not to withhold lifesaving organs); recommendation
number 19 (recommendation to take
steps to ensure that the donors’ wishes
are fulfilled); and recommendation
number 20 (recommendation that the
VerDate Aug<31>2005
15:52 Jan 10, 2007
Jkt 211001
State update the law governing
anatomical gifts). The initial UAGA was
written in 1968.
The purpose of this call is to hear
discussion from the ACOT members
and, if the Committee chooses, to
develop a recommendation from the
ACOT to the Secretary concerning the
revised UAGA.
Dated: January 3, 2007.
Elizabeth M. Duke,
Administrator.
[FR Doc. E7–212 Filed 1–10–07; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the meeting of the
President’s Cancer Panel.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in section
552b(c)(9)(B), Title 5 U.S.C., as
amended, because the premature
disclosure of information and the
discussions would be likely to
significantly frustrate implementation of
recommendations.
Name of Committee: President’s Cancer
Panel.
Date: February 12, 2007.
Open: February 12, 2007, 8 a.m.–4 p.m.
Agenda: Promoting Healthy Lifestyles to
Reduce the Risk of Cancer.
Place: University of Mississippi Medical
Center, 2500 North State Street, Jackson, MS
39216.
Closed: February 12, 2007, 4 p.m.–6 p.m.
Agenda: The Panel will discuss the
Promoting Healthy Lifestyles to Reduce the
Risk of Cancer and discuss potential topics
for the 2007/2008 series.
Place: University of Mississippi Medical
Center, 2500 North State Street, Jackson, MS
39216.
Contact Person: Abby Sandler, PhD,
Executive Secretary, National Cancer
Institute, National Institutes of Health,
Building 6116, Room 212, 6116 Executive
Boulevard, Bethesda, MD 20892, 301/451–
9399.
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
1335
Any interested person may file written
comments with the committee by forwarding
the comments to the Contact Person listed on
this notice. The comments should include
the name, address, telephone number and,
when applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page:
deainfo.nci.nih.gov/advisory/pcp/pcp.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: January 4, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–68 Filed 1–10–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel CA 07–503,
‘‘Advanced Technology Radiation Therapy
Clinical Trials Support (ATC) (U24).’’
Name: March 5, 2007.
Time: 12 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6130
Executive Blvd., Conference Room D,
Rockville, MD 20852 (Telephone Conference
Call).
Contact Person: Kenneth L. Bielat, PhD,
Scientific Review Administrator, Division of
Extramural Activities, National Cancer
E:\FR\FM\11JAN1.SGM
11JAN1
]]>Agencies
[Federal Register Volume 72, Number 7 (Thursday, January 11, 2007)]
[Notices]
[Pages 1334-1335]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-212]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Advisory Committee on Organ Transplantation
AGENCY: Health Resources and Services Administration (HRSA), HHS.
ACTION: Notice of ACOT Meeting to be held by Conference Call.
-----------------------------------------------------------------------
SUMMARY: The Advisory Committee on Organ Transplantation (ACOT) will be
conducting a conference call to discuss
[[Page 1335]]
the revision of the Uniform Anatomical Gift Act (UAGA).
DATES: The conference call will be held on January 26, 2007, at 12 noon
to 1 p.m. EST. Participants must dial: (888) 946-7610 and enter the
corresponding pass code 30431. For security reasons, the pass code
30431 and Remy Aronoff's name, as call leader, are required to join the
call. Participants should call no later than 11:50 a.m. EST in order
for the logistics to be set up. Participants are asked to register for
the conference by contacting Diane Cheslosky at (301) 443-6839 or e-
mail diane.cheslosky@hrsa.hhs.gov. The registration deadline is January
24, 2007. The Department will try to accommodate those wishing to
participate in the call.
Any member of the public can submit written materials that will be
distributed to Committee members prior to the conference call. Parties
wishing to submit written comments should ensure that the comments are
postmarked or e-mailed no later than January 24, 2007, for
consideration. Comments should be submitted to Remy Aronoff, Executive
Secretary, ACOT, Healthcare Systems Bureau, HRSA, Parklawn Building,
Room 12C-06, 5600 Fishers Lane, Rockville, Maryland 20857; telephone
(301) 443-3264; fax (301) 594-6095; or e-mail:
remy.aronoff@hrsa.hhs.gov.
Members of the public can present oral comments during the
conference call during the public comment period. If a member of the
public wishes to speak, the Department should be notified at the time
the participant registers. Other members of the public will be
allocated time if time permits.
FOR FURTHER INFORMATION CONTACT: Remy Aronoff, Executive Secretary,
ACOT, Healthcare Systems Bureau, HRSA, Parklawn Building, Room 12C-06,
5600 Fishers Lane, Rockville, Maryland 20857; telephone (301) 443-3264;
fax (301) 594-6095; or e-mail: remy.aronoff@hrsa.hhs.gov.
SUPPLEMENTARY INFORMATION: The UAGA is a model law drafted by the
National Conference of Commissioners on Uniform State Laws in an effort
to achieve uniformity among the anatomical gift laws of the States.
Three ACOT recommendations provided a stimulus for revising the UAGA.
In particular, recommendation number 10 (recommendation to engage in
legislative strategies to encourage medical examiners not to withhold
life-saving organs); recommendation number 19 (recommendation to take
steps to ensure that the donors' wishes are fulfilled); and
recommendation number 20 (recommendation that the State update the law
governing anatomical gifts). The initial UAGA was written in 1968.
The purpose of this call is to hear discussion from the ACOT
members and, if the Committee chooses, to develop a recommendation from
the ACOT to the Secretary concerning the revised UAGA.
Dated: January 3, 2007.
Elizabeth M. Duke,
Administrator.
[FR Doc. E7-212 Filed 1-10-07; 8:45 am]
BILLING CODE 4165-15-P
